Glenmark Pharmaceuticals Limited (NSE: GLENMARK)

Glenmark Pharmaceuticals Revenue

Glenmark Pharmaceuticals had revenue of 34.34B INR in the quarter ending September 30, 2024, with 7.06% growth. This brings the company's revenue in the last twelve months to 130.80B, down -4.88% year-over-year. In the fiscal year ending March 31, 2024, Glenmark Pharmaceuticals had annual revenue of 126.45B with 8.49% growth.

• Revenue (ttm): 130.80B
• Revenue Growth: -4.88%
• P/S Ratio: 3.16
• Revenue / Employee: 8.73M
• Employees: 14,989
• Market Cap: 413.80B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	126.45B	9.90B	8.49%
Mar 31, 2023	116.56B	-6.49B	-5.28%
Mar 31, 2022	123.05B	13.61B	12.44%
Mar 31, 2021	109.44B	2.87B	2.69%
Mar 31, 2020	106.57B	7.92B	8.03%